-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-11
Build a two-dimensional readout for mRNA delivery: Cy5 reports where the payload travels, while EGFP reports whether it produces functional protein. This practical workflow helps researchers validate nanoparticles, optimize macrophage delivery, and separate uptake from translation-related failure.
-
Intra-Articular RTX for Osteoarthritic Pain
2026-09-11
The 2025 review by Iadarola and colleagues evaluates intra-articular Resiniferatoxin as a local TRPV1-directed intervention for osteoarthritic pain. Its central innovation is the integration of cellular, animal, veterinary, and early human evidence around chemical inactivation of TRPV1-positive nociceptive terminals, while emphasizing how injection dose, volume, and tissue distribution may determine clinical reproducibility.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-10
The Hoechst 33342/PI Double Staining Kit (SKU K2237) supports fluorescence-based comparison of nuclear chromatin changes and loss of membrane integrity in cultured cells. It is intended for non-clinical research workflows, not diagnostic, therapeutic, or medical decision-making applications.
-
Fluo-4 AM for Mechanistic Calcium Assays
2026-09-10
Fluo-4 AM enables sensitive intracellular calcium concentration measurement, but its greatest value emerges when fluorescence is connected to receptor trafficking and disease biology. This article translates recent GPR107 diabetic nephropathy findings into a rigorous calcium signaling assay strategy.
-
DFCP1 Controls Starvation-Driven ATGL Lipolysis
2026-09-09
The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid droplet catabolism that recruits ATGL to droplets during starvation while limiting its dynamic dissociation. This mechanism refines current models of lipolysis by showing that ATGL localization and residence time, rather than recruitment alone, can determine lipid mobilization.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-09-09
The reference study developed a tumor-microenvironment-responsive nanoparticle system for systemic PTEN mRNA delivery in trastuzumab-resistant breast cancer. By restoring PTEN expression and restraining PI3K/Akt signaling, the platform provides a mechanistic strategy for improving antibody response while highlighting the importance of delivery design.
-
7-AAD Cell Viability Assay Kit for CAR-T
2026-09-08
Learn how the 7-AAD Cell Viability Assay Kit can convert membrane damage into interpretable evidence during CD38 CAR-T development. This article links structural binder engineering with assay design, gating strategy, spectral planning, and the biological limits of late-apoptosis and necrosis measurements.
-
SB 203580 for Reproducible Cell Assays
2026-09-08
Learn how SB 203580 (SKU A8254) can help researchers separate p38 MAPK-driven stress responses from assay noise in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers mechanism, solvent handling, optimization, interpretation, and practical vendor selection.
-
Epmedin C Blocks Caspase-1 in DON-Treated Macrophages
2026-09-07
This study defines a caspase-1/IL-1β-centered mechanism for low-dose deoxynivalenol immunotoxicity in chicken macrophages and identifies epmedin C as a protective flavonoid. Its combination of cellular, computational, coculture, and chick experiments connects inflammatory signaling with ROS accumulation and provides a mechanistic framework for poultry mycotoxin detoxification.
-
Dihydroethidium (DHE) for Superoxide Research
2026-09-07
Dihydroethidium, also called hydroethidine, is a cell-permeable redox probe used for intracellular superoxide and oxidative stress studies. Its red fluorescence is informative only when oxidation chemistry, controls, imaging settings, and product handling are defined.
-
NamiRNA–LNP Therapy in Pancreatic Cancer
2026-09-05
Yu et al. show that miR-200c suppresses pancreatic cancer through two separable regulatory routes: nuclear activation of PTPN6 transcription through an enhancer and post-transcriptional repression of CDH17. The study further demonstrates that lipid nanoparticle delivery of miR-200c produces antitumor activity in vivo, while highlighting how one miRNA can coordinate transcriptional and post-transcriptional control.
-
AI-10-49: Reading the CBFβ-SMMHC Signal
2026-09-04
AI-10-49, a selective CBFβ-SMMHC inhibitor, provides a mechanistic way to connect fusion-protein disruption with RUNX1 chromatin recovery and leukemia dependency. This article explains how to interpret target engagement, MYCN–eIF4G1 signaling, and functional responses without confusing downstream biomarkers for direct drug effects.
-
Recombinant Mouse SHH: Assay Design for Translation
2026-09-04
Recombinant Mouse Sonic Hedgehog is a powerful tool for dissecting morphogen signaling, but its value depends on species-aware assay design. This guide connects SHH protein selection, functional potency testing, and comparative developmental evidence to improve translational interpretation.
-
DPPH: From Radical Readout to Translational Strategy
2026-09-03
DPPH converts radical-scavenging chemistry into a rapid, interpretable signal. Used alongside orthogonal assays and chemical profiling, it can help translational teams prioritize natural products and drug-discovery candidates without overstating clinical relevance.
-
EdU Imaging Kits (Cy5): Practical Workflow
2026-09-03
EdU Imaging Kits (Cy5), SKU K1076, provide a morphology-preserving way to identify cells synthesizing DNA during S phase for microscopy or flow cytometry. The assay is appropriate for proliferation, cell-cycle, and genotoxicity workflows, but EdU positivity should not be treated alone as proof of completed cell division, viability, or a specific DNA-damage mechanism.